HBC 961102a
|
46 |
59/M |
Left hemiparesis |
Frontal metastasis from lung carcinoma |
Phenobarbital/100 mg/10 |
HBC 970105a,b
|
32 |
56/F |
High intracranial pressure |
Hemorrhage from capsulostriatal, cavernoma |
Phenobarbital/100 mg/35 |
HBC 980510b,c,d,e
|
46 |
60/M |
High intracranial pressure |
Frontal meningioma |
Valproate/1000 mg/30 |
HBC 980611b,c,d,e
|
10 |
64/F |
High intracranial pressure |
Orbito-frontal meningioma |
Valproate/1000 mg/30 |
HBC 981114d
|
21 |
65/M |
Absent |
Temporal fossa meningioma |
Phenobarbital/100 mg/14 |
HBC 981115 |
10 |
64/M |
Anosmia |
Orbito-frontal meningioma |
Phenobarbital/100 mg/21 |
HBC 981219c,d,e
|
9 |
60/F |
Absent |
Frontal metastasis from breast cancer |
Phenobarbital/100 mg/30, dexamethasone 16 mg/14 |
HBC 030129 |
8 |
64/M |
High intracranial pressure |
Frontal meningioma |
Valproate/1000 mg/30 |
HBC 040925d,e
|
7 |
58/F |
Visual field defect |
Parasagittal meningioma |
Oxcarbazepine/900 mg/2 |
HBC 050230 |
7 |
37/F |
Absent |
Paraventricular, meningioma |
Oxcarbazepine/900 mg/15, dexamethasone 16 mg/15 |
HBC 050231 |
8 |
80/F |
High intracranial pressure |
Hemorrhagic stroke |
None |
HBC 070532 |
19 |
64/F |
Absent |
Parasagittal meningioma |
Oxcarbazepine/900 mg/2 |
HBC 070533 |
10 |
49/F |
Left hemiparesis |
Basal nuclei glioma |
Oxcarbazepine/900 mg/10, dexamethasone 16 mg/10 |